Cargando…
Is It Time to Anticipate the Use of PARP Inhibition in Prostate Cancer Patients?
The increasing diffusion of genetic analysis regarding the pathogenetic variants (PVs) of genes involved in DNA Damage Repair (DDR) mechanisms and the development of Poly ADP ribose polymerase (PARP) inhibitors (PARPis) led to the first valid precision medicine option tailored toward metastatic pros...
Autores principales: | Sciarra, Alessandro, Santarelli, Valerio, Santodirocco, Lorenzo, Frisenda, Marco, Salciccia, Stefano, Casale, Paolo, Forte, Flavio, Mariotti, Gianna, Moriconi, Martina, Cattarino, Susanna, Sciarra, Beatrice, Bevilacqua, Giulio, Gentilucci, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528501/ https://www.ncbi.nlm.nih.gov/pubmed/37754499 http://dx.doi.org/10.3390/curroncol30090584 |
Ejemplares similares
-
Exosome Analysis in Prostate Cancer: How They Can Improve Biomarkers’ Performance
por: Salciccia, Stefano, et al.
Publicado: (2023) -
How to Predict Outcomes from a Biofeedback and Pelvic Floor Muscle Electric Stimulation Program in Patients with Urinary Incontinence after Radical Prostatectomy
por: Salciccia, Stefano, et al.
Publicado: (2021) -
How the Analysis of the Pathogenetic Variants of DDR Genes Will Change the Management of Prostate Cancer Patients
por: Sciarra, Alessandro, et al.
Publicado: (2022) -
Prognostic Value of Albumin to Globulin Ratio in Non-Metastatic and Metastatic Prostate Cancer Patients: A Meta-Analysis and Systematic Review
por: Salciccia, Stefano, et al.
Publicado: (2022) -
Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical review
por: Sciarra, Alessandro, et al.
Publicado: (2016)